1. Home
  2. INCR

as 12-18-2024 9:52am EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.

Founded: 1994 Country:
Israel
Israel
Employees: N/A City: N/A
Market Cap: 65.3M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 29.6K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.38 EPS Growth: N/A
52 Week Low/High: $1.17 - $3.72 Next Earning Date: 12-24-2024
Revenue: $72,420,918 Revenue Growth: -34.26%
Revenue Growth (this year): -18.24% Revenue Growth (next year): 39.30%

INCR Daily Stock ML Predictions

Share on Social Networks: